The Effects of Diabetic Polyneuropathy and Autonomic Neuropathy on Bone Turnover

2021 ◽  
Author(s):  
Zehra Kara ◽  
Mutlu Güneş ◽  
İbrahim Murat Bolayırlı ◽  
Zeynep Oşar Siva
Keyword(s):  
Bone Turnover ◽  
Autonomic Neuropathy ◽  
Diabetic Polyneuropathy

scholarly journals Autonomic Diabetic Polyneuropathy Variants: Possible Correction

Doctor Ru ◽  
2021 ◽  
Vol 20 (2) ◽  
pp. 60-66
Author(s):  
A.V. Zilov ◽  
◽  
Keyword(s):  
Diabetes Mellitus ◽  
Autonomic Neuropathy ◽  
Lipoic Acid ◽  
Diabetic Polyneuropathy ◽  
Clinical Aspects ◽  
Diabetic Patients ◽  
Slowing Down ◽  
Key Points ◽  
Delayed Complications ◽  
Clinical Interest

Objective of the Review: To analyse the incidence of polyneuropathy in diabetic patients focusing on autonomic neuropathy. Key Points. Polyneuropathy is one of the most common delayed complications of diabetes mellitus (DM); the condition has numerous clinical aspects. Major polyneuropathy studies focus on assessment, prevention and management of pain caused by sensory and sensory-and-motor defects, prevention of ulceration and Charcot foot. At the same time, various autonomic neuropathy variants in diabetic patients have either been studied not thoroughly enough, or are outside of clinical interest. Still, prevention and pathogenic effect from autonomic neuropathy are similar to those used in other types of diabetic neuropathy. We describe major pathogenic links in nerve fibre damaging and clinical forms of autonomic neuropathy. Major studies of the use of α-lipoic acid in DM are presented. Conclusion. α-lipoic acid medications are efficient in slowing down various forms of autonomic neuropathy. Dose-dependent action of these medications, adequate therapy duration (at least 3 months as a course of medication), improved glycaemic control in patients with DM are essential for autonomic neuropathy prevention and slowing down. Keywords: diabetes mellitus; diabetic polyneuropathy; diabetic autonomic polyneuropathy; α-lipoic acid.

Variable Relationship Between Peripheral Somatic and Autonomic Neuropathy in Patients with Different Syndromes of Diabetic Polyneuropathy

Diabetes ◽  
1986 ◽  
Vol 35 (2) ◽  
pp. 192-197 ◽  
Author(s):  
R. J. Young ◽  
Y. Q. Zhou ◽  
E. Rodriguez ◽  
R. J. Prescott ◽  
D. J. Ewing ◽  
...  
Keyword(s):  
Autonomic Neuropathy ◽  
Diabetic Polyneuropathy

Variable relationship between peripheral somatic and autonomic neuropathy in patients with different syndromes of diabetic polyneuropathy

Diabetes ◽  
1986 ◽  
Vol 35 (2) ◽  
pp. 192-197 ◽  
Author(s):  
R. J. Young ◽  
Y. Q. Zhou ◽  
E. Rodriguez ◽  
R. J. Prescott ◽  
D. J. Ewing ◽  
...  
Keyword(s):  
Autonomic Neuropathy ◽  
Diabetic Polyneuropathy

scholarly journals Cardiac diabetic autonomic neuropathy

2020 ◽  
pp. 94-102
Author(s):  
L. T. Akhmedzhanova ◽  
T. A. Belyakova ◽  
Yu. A. Podkovko ◽  
Yu. M. Shor
Keyword(s):  
Diabetes Mellitus ◽  
Autonomic Neuropathy ◽  
Clinical Case ◽  
Clinical Symptoms ◽  
Early Stage ◽  
Clinical Manifestations ◽  
Public Health Problem ◽  
Diabetic Polyneuropathy ◽  
Neurological Complications ◽  
Cardiac Autonomic Neuropathy

The prevalence of diabetes mellitus (DM) is steadily increasing and represents a significant public health problem. At the same time, the incidence of neurological complications of diabetes mellitus, especially diabetic polyneuropathy, is increasing. Cardiac autonomic neuropathy, a form of diabetic polyneuropathy, is the most serious complication of diabetes mellitus, as it is an independent risk factor for cardiovascular complications in patients with diabetes mellitus and is associated with increased mortality. Due to prolonged asymptomatic flow, cardiac autonomic neuropathy is often diagnosed at a late stage when treatment is not very effective. A targeted search for clinical symptoms of the disease and especially the conduct of cardiovascular tests, which make it possible to diagnose the pathology at an early stage, is essential. Clinical manifestations of cardiac autonomic neuropathy, methods of clinical and instrumental diagnostics, treatment of the disease are considered in detail in the article. The clinical case of a patient with type 2 diabetes mellitus and cardiac autonomic neuropathy, represented by orthostatic hypotension, which is the most disabling symptom, is considered. On the example of a clinical case the medicamentous and non-medicamentous approaches to treatment are discussed, as well as the role of antioxidant therapy, in particular, the preparation of alpha-lipoic acid («Berlithion») in the treatment of cardiac autonomic neuropathy.

Sign in / Sign up

Export Citation Format

Share Document